Abstract
The emergence and reemergence of mosquito-borne diseases in Brazil such as Yellow Fever, Zika, Chikungunya, and Dengue have had serious impacts on public health. Concerns have been raised due to the rapid dissemination of the chikungunya virus (CHIKV) across the country since its first detection in 2014 in Northeast Brazil. Faced with this scenario, on-site training activities in genomic surveillance carried out in partnership with the National Network of Public Health Laboratories have led to the generation of 422 CHIKV genomes from 12 Brazilian states over the past two years (2021-2022), a period that has seen more than 312 thousand chikungunya fever cases reported in the country. These new genomes increased the amount of available data and allowed a more comprehensive characterization of the dispersion dynamics of the CHIKV East-Central-South-African (ECSA) lineage in Brazil. Tree branching patterns revealed the emergence and expansion of two distinct subclades. Phylogeographic analysis indicated that the northeast region has been the leading hub of virus spread towards other regions. Increased frequency of C>T transitions among the new genomes suggested that host restriction factors from the immune system such as ADAR and AID/APOBEC deaminases might be driving CHIKV ECSA lineage genetic diversity in Brazil.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by The Pan American Health Organization (PAHO/WHO), the Brazilian Ministry of Health grant SCON2021-00180 (Coordenacao Geral de Laboratorio de Saude Publica-CGLAB and Coordenacao Geral de Vigilancia de Arboviroses-CGARB), the National Institutes of Health USA grant U01 AI151698 for the United World Arbovirus Research Network (UWARN). We thank the State Health Secretariats and the epidemiological surveillance services of Brazilian states and municipalities for all the support provided. JX is supported by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior-Brasil (CAPES)-Finance Code 001. MG is funded by PON Ricerca e Innovazione 2014-2020.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study protocol was reviewed and approved by Research Ethics Committee of the Universidade Federal de Minas Gerais with approval No. 32912820.6.1001.5149. The project was approved by the Pan American World Health Organization (PAHO) and the Brazilian Ministry of Health (MoH) as part of the arboviral genomic surveillance efforts within the terms of Resolution 510/2016 of CONEP (Comissao Nacional de Etica em Pesquisa, Ministerio da Saude; National Ethical Committee for Research, Ministry of Health). This authorizes the use of clinical samples collected in the Brazilian Central Public Health Laboratories to accelerate knowledge building and contribute to surveillance and outbreak response.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
The Author list was updated to include K.S.T.
Data Availability
New sequences have been deposited in GenBank. Input files used for the phylogenetic and mutational profile analyses will be available at the GitHub repository https://github.com/genomicsurveillance. All data produced in the present study are available upon reasonable request to the authors.
